TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Chimeric Therapeutics Ltd. ( (AU:CHM) ) just unveiled an update.
Chimeric Therapeutics Ltd. has announced the quotation of 387,577,500 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions, potentially enhancing the company’s financial flexibility and market presence, which could have significant implications for its growth strategy and stakeholder engagement.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of innovative therapies. The company specializes in advancing cell therapies to treat cancer, aiming to improve patient outcomes through cutting-edge scientific research and development.
Technical Sentiment Signal: Sell
Current Market Cap: A$13.02M
Find detailed analytics on CHM stock on TipRanks’ Stock Analysis page.